On the occasion, the Vice President said that he believed that ROTAVAC is an example of a true social innovation that was realized through a partnership between scientists from India and the USA.
He added that India is committed to the goal of protecting the health of each and every one of its children. Vicepresident added that India is firmly committed to ending morbidity and mortality in children caused due to diarrhoea by 2022.
The first generation, Rotavirus vaccine, ROTAVAC developed under a Public-Private Partnership with the Department of Biotechnology, Govt. of India, has put India on the global map for setting new standards in pharmaceutical Research and Development.